Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 28 entries
Sorted by: Best Match Show Resources per page
Assessing the efficiency of free energy calculation methods.

The Journal of chemical physics

Rodriguez-Gomez D, Darve E, Pohorille A.
PMID: 15268518
J Chem Phys. 2004 Feb 22;120(8):3563-78. doi: 10.1063/1.1642607.

The efficiencies of two recently developed methods for calculating free energy changes along a generalized coordinate in a system are discussed in the context of other, related approaches. One method is based on Jarzynski's identity [Phys. Rev. Lett. 78,...

Cite
Rodriguez-Gomez D, Darve E, Pohorille A. Assessing the efficiency of free energy calculation methods. J Chem Phys. 2004;120(8):3563-78doi: 10.1063/1.1642607.
Rodriguez-Gomez, D., Darve, E., & Pohorille, A. (2004). Assessing the efficiency of free energy calculation methods. The Journal of chemical physics, 120(8), 3563-78. https://doi.org/10.1063/1.1642607
Rodriguez-Gomez, David, et al. "Assessing the efficiency of free energy calculation methods." The Journal of chemical physics vol. 120,8 (2004): 3563-78. doi: https://doi.org/10.1063/1.1642607
Rodriguez-Gomez D, Darve E, Pohorille A. Assessing the efficiency of free energy calculation methods. J Chem Phys. 2004 Feb 22;120(8):3563-78. doi: 10.1063/1.1642607. PMID: 15268518.
Copy Download .nbib Format: NLM
NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel.

Applied optics

Patel MR, Antoine P, Mason J, Leese M, Hathi B, Stevens AH, Dawson D, Gow J, Ringrose T, Holmes J, Lewis SR, Beghuin D, van Donink P, Ligot R, Dewandel JL, Hu D, Bates D, Cole R, Drummond R, Thomas IR, Depiesse C, Neefs E, Equeter E, Ristic B, Berkenbosch S, Bolsée D, Willame Y, Vandaele AC, Lesschaeve S, De Vos L, Van Vooren N, Thibert T, Mazy E, Rodriguez-Gomez J, Morales R, Candini GP, Pastor-Morales MC, Sanz R, Aparicio Del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, BenMoussa A, Giordanengo B, Gissot S, Bellucci G, Lopez-Moreno JJ.
PMID: 28375240
Appl Opt. 2017 Apr 01;56(10):2771-2782. doi: 10.1364/AO.56.002771.

NOMAD is a spectrometer suite on board the ESA/Roscosmos ExoMars Trace Gas Orbiter, which launched in March 2016. NOMAD consists of two infrared channels and one ultraviolet and visible channel, allowing the instrument to perform observations quasi-constantly, by taking...

Cite
Patel MR, Antoine P, Mason J, et al. NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel. Appl Opt. 2017;56(10):2771-2782doi: 10.1364/AO.56.002771.
Patel, M. R., Antoine, P., Mason, J., Leese, M., Hathi, B., Stevens, A. H., Dawson, D., Gow, J., Ringrose, T., Holmes, J., Lewis, S. R., Beghuin, D., van Donink, P., Ligot, R., Dewandel, J. L., Hu, D., Bates, D., Cole, R., Drummond, R., Thomas, I. R., Depiesse, C., Neefs, E., Equeter, E., Ristic, B., Berkenbosch, S., Bolsée, D., Willame, Y., Vandaele, A. C., Lesschaeve, S., De Vos, L., Van Vooren, N., Thibert, T., Mazy, E., Rodriguez-Gomez, J., Morales, R., Candini, G. P., Pastor-Morales, M. C., Sanz, R., Aparicio Del Moral, B., Jeronimo-Zafra, J. M., Gómez-López, J. M., Alonso-Rodrigo, G., Pérez-Grande, I., Cubas, J., Gomez-Sanjuan, A. M., Navarro-Medina, F., BenMoussa, A., Giordanengo, B., Gissot, S., Bellucci, G., & Lopez-Moreno, J. J. (2017). NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel. Applied optics, 56(10), 2771-2782. https://doi.org/10.1364/AO.56.002771
Patel, Manish R, et al. "NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel." Applied optics vol. 56,10 (2017): 2771-2782. doi: https://doi.org/10.1364/AO.56.002771
Patel MR, Antoine P, Mason J, Leese M, Hathi B, Stevens AH, Dawson D, Gow J, Ringrose T, Holmes J, Lewis SR, Beghuin D, van Donink P, Ligot R, Dewandel JL, Hu D, Bates D, Cole R, Drummond R, Thomas IR, Depiesse C, Neefs E, Equeter E, Ristic B, Berkenbosch S, Bolsée D, Willame Y, Vandaele AC, Lesschaeve S, De Vos L, Van Vooren N, Thibert T, Mazy E, Rodriguez-Gomez J, Morales R, Candini GP, Pastor-Morales MC, Sanz R, Aparicio Del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, BenMoussa A, Giordanengo B, Gissot S, Bellucci G, Lopez-Moreno JJ. NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel. Appl Opt. 2017 Apr 01;56(10):2771-2782. doi: 10.1364/AO.56.002771. PMID: 28375240.
Copy Download .nbib Format: NLM
Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis.

Journal of thrombosis and thrombolysis

Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C.
PMID: 30506351
J Thromb Thrombolysis. 2019 Jan;47(1):41. doi: 10.1007/s11239-018-1787-y.

The original version of the article unfortunately contained an error in conflict of interest. This erratum is published with the correct conflict of interest.

Cite
Rosovsky R, Chang Y, Rosenfield K, et al. Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019;47(1):41doi: 10.1007/s11239-018-1787-y.
Rosovsky, R., Chang, Y., Rosenfield, K., Channick, R., Jaff, M. R., Weinberg, I., Sundt, T., Witkin, A., Rodriguez-Lopez, J., Parry, B. A., Harshbarger, S., Hariharan, P., & Kabrhel, C. (2019). Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. Journal of thrombosis and thrombolysis, 47(1), 41. https://doi.org/10.1007/s11239-018-1787-y
Rosovsky, Rachel, et al. "Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis." Journal of thrombosis and thrombolysis vol. 47,1 (2019): 41. doi: https://doi.org/10.1007/s11239-018-1787-y
Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C. Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan;47(1):41. doi: 10.1007/s11239-018-1787-y. PMID: 30506351.
Copy Download .nbib Format: NLM
Cerebrovascular and cardiovascular disease burden in patients with hereditary hemorrhagic telangiectasia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Farooqui M, Suriya S, Qeadan F, Vigil C, Wegele A, Ikram A, Quadri SA, Robinson M, Rodriguez-Lopez J, Ortega-Gutierrez S, Zafar A.
PMID: 33779866
Neurol Sci. 2021 Dec;42(12):5117-5122. doi: 10.1007/s10072-021-05135-z. Epub 2021 Mar 29.

INTRODUCTION: Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease with prevalence of approximately 1 in 5000-10,000. We evaluated the prevalence and association of cerebrovascular and cardiovascular comorbidities in HHT patients using national database.METHODS: Retrospective observational study was performed...

Cite
Farooqui M, Suriya S, Qeadan F, et al. Cerebrovascular and cardiovascular disease burden in patients with hereditary hemorrhagic telangiectasia. Neurol Sci. 2021;42(12):5117-5122doi: 10.1007/s10072-021-05135-z.
Farooqui, M., Suriya, S., Qeadan, F., Vigil, C., Wegele, A., Ikram, A., Quadri, S. A., Robinson, M., Rodriguez-Lopez, J., Ortega-Gutierrez, S., & Zafar, A. (2021). Cerebrovascular and cardiovascular disease burden in patients with hereditary hemorrhagic telangiectasia. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42(12), 5117-5122. https://doi.org/10.1007/s10072-021-05135-z
Farooqui, Mudassir, et al. "Cerebrovascular and cardiovascular disease burden in patients with hereditary hemorrhagic telangiectasia." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. 42,12 (2021): 5117-5122. doi: https://doi.org/10.1007/s10072-021-05135-z
Farooqui M, Suriya S, Qeadan F, Vigil C, Wegele A, Ikram A, Quadri SA, Robinson M, Rodriguez-Lopez J, Ortega-Gutierrez S, Zafar A. Cerebrovascular and cardiovascular disease burden in patients with hereditary hemorrhagic telangiectasia. Neurol Sci. 2021 Dec;42(12):5117-5122. doi: 10.1007/s10072-021-05135-z. Epub 2021 Mar 29. PMID: 33779866.
Copy Download .nbib Format: NLM
Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections.

American journal of therapeutics

Gentry LO, Rodriguez-Gomez G, Pien F, Cubeddu L, Holley HP, Buaron K, Giguere G, Collins JJ.
PMID: 11862252
Am J Ther. 1996 Mar;3(3):212-218.

BACKGROUND: Skin and skin structure infections are among the most common infectious diagnoses in both the hospital and community settings. If untreated, these infections can produce serious complications. Successful antimicrobial therapy for these infections requires coverage against the causative...

Cite
Gentry LO, Rodriguez-Gomez G, Pien F, et al. Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections. Am J Ther. 1996;3(3):212-218
Gentry, L. O., Rodriguez-Gomez, G., Pien, F., Cubeddu, L., Holley, H. P., Buaron, K., Giguere, G., & Collins, J. J. (1996). Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections. American journal of therapeutics, 3(3), 212-218.
Gentry, Layne O., et al. "Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections." American journal of therapeutics vol. 3,3 (1996): 212-218.
Gentry LO, Rodriguez-Gomez G, Pien F, Cubeddu L, Holley HP, Buaron K, Giguere G, Collins JJ. Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections. Am J Ther. 1996 Mar;3(3):212-218. PMID: 11862252.
Copy Download .nbib Format: NLM
Nickel Particles Selectively Confined in the Mesoporous Channels of SBA-15 Yielding a Very Stable Catalyst for DRM Reaction.

The journal of physical chemistry. B

Rodriguez-Gomez A, Pereñiguez R, Caballero A.
PMID: 28723096
J Phys Chem B. 2018 Jan 18;122(2):500-510. doi: 10.1021/acs.jpcb.7b03835. Epub 2017 Aug 11.

A series of four Ni catalysts supported on SBA-15 and on a high SiO

Cite
Rodriguez-Gomez A, Pereñiguez R, Caballero A. Nickel Particles Selectively Confined in the Mesoporous Channels of SBA-15 Yielding a Very Stable Catalyst for DRM Reaction. J Phys Chem B. 2017;122(2):500-510doi: 10.1021/acs.jpcb.7b03835.
Rodriguez-Gomez, A., Pereñiguez, R., & Caballero, A. (2018). Nickel Particles Selectively Confined in the Mesoporous Channels of SBA-15 Yielding a Very Stable Catalyst for DRM Reaction. The journal of physical chemistry. B, 122(2), 500-510. https://doi.org/10.1021/acs.jpcb.7b03835
Rodriguez-Gomez, Alberto, et al. "Nickel Particles Selectively Confined in the Mesoporous Channels of SBA-15 Yielding a Very Stable Catalyst for DRM Reaction." The journal of physical chemistry. B vol. 122,2 (2018): 500-510. doi: https://doi.org/10.1021/acs.jpcb.7b03835
Rodriguez-Gomez A, Pereñiguez R, Caballero A. Nickel Particles Selectively Confined in the Mesoporous Channels of SBA-15 Yielding a Very Stable Catalyst for DRM Reaction. J Phys Chem B. 2018 Jan 18;122(2):500-510. doi: 10.1021/acs.jpcb.7b03835. Epub 2017 Aug 11. PMID: 28723096.
Copy Download .nbib Format: NLM
Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study.

EGEMS (Washington, DC)

Thorpe LE, McVeigh KH, Perlman S, Chan PY, Bartley K, Schreibstein L, Rodriguez-Lopez J, Newton-Dame R.
PMID: 28154836
EGEMS (Wash DC). 2016 Dec 15;4(1):1266. doi: 10.13063/2327-9214.1266. eCollection 2016.

INTRODUCTION: Electronic health records (EHRs) can potentially extend chronic disease surveillance, but few EHR-based initiatives tracking population-based metrics have been validated for accuracy. We designed a new EHR-based population health surveillance system for New York City (NYC) known as...

Cite
Thorpe LE, McVeigh KH, Perlman S, et al. Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study. EGEMS (Wash DC). 2016;4(1):1266doi: 10.13063/2327-9214.1266.
Thorpe, L. E., McVeigh, K. H., Perlman, S., Chan, P. Y., Bartley, K., Schreibstein, L., Rodriguez-Lopez, J., & Newton-Dame, R. (2016). Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study. EGEMS (Washington, DC), 4(1), 1266. https://doi.org/10.13063/2327-9214.1266
Thorpe, Lorna E, et al. "Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study." EGEMS (Washington, DC) vol. 4,1 (2016): 1266. doi: https://doi.org/10.13063/2327-9214.1266
Thorpe LE, McVeigh KH, Perlman S, Chan PY, Bartley K, Schreibstein L, Rodriguez-Lopez J, Newton-Dame R. Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study. EGEMS (Wash DC). 2016 Dec 15;4(1):1266. doi: 10.13063/2327-9214.1266. eCollection 2016. PMID: 28154836; PMCID: PMC5226388.
Copy Download .nbib Format: NLM
NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 1--design, manufacturing and testing of the infrared channels.

Applied optics

Neefs E, Vandaele AC, Drummond R, Thomas IR, Berkenbosch S, Clairquin R, Delanoye S, Ristic B, Maes J, Bonnewijn S, Pieck G, Equeter E, Depiesse C, Daerden F, Van Ransbeeck E, Nevejans D, Rodriguez-Gómez J, López-Moreno JJ, Sanz R, Morales R, Candini GP, Pastor-Morales MC, Aparicio del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, Thibert T, Patel MR, Bellucci G, De Vos L, Lesschaeve S, Van Vooren N, Moelans W, Aballea L, Glorieux S, Baeke A, Kendall D, De Neef J, Soenen A, Puech PY, Ward J, Jamoye JF, Diez D, Vicario-Arroyo A, Jankowski M.
PMID: 26479628
Appl Opt. 2015 Oct 01;54(28):8494-520. doi: 10.1364/AO.54.008494.

NOMAD is a spectrometer suite on board ESA's ExoMars trace gas orbiter due for launch in January 2016. NOMAD consists of two infrared channels and one ultraviolet and visible channel allowing the instrument to perform observations quasi-constantly, by taking...

Cite
Neefs E, Vandaele AC, Drummond R, et al. NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 1--design, manufacturing and testing of the infrared channels. Appl Opt. 2015;54(28):8494-520doi: 10.1364/AO.54.008494.
Neefs, E., Vandaele, A. C., Drummond, R., Thomas, I. R., Berkenbosch, S., Clairquin, R., Delanoye, S., Ristic, B., Maes, J., Bonnewijn, S., Pieck, G., Equeter, E., Depiesse, C., Daerden, F., Van Ransbeeck, E., Nevejans, D., Rodriguez-Gómez, J., López-Moreno, J. J., Sanz, R., Morales, R., Candini, G. P., Pastor-Morales, M. C., Aparicio del Moral, B., Jeronimo-Zafra, J. M., Gómez-López, J. M., Alonso-Rodrigo, G., Pérez-Grande, I., Cubas, J., Gomez-Sanjuan, A. M., Navarro-Medina, F., Thibert, T., Patel, M. R., Bellucci, G., De Vos, L., Lesschaeve, S., Van Vooren, N., Moelans, W., Aballea, L., Glorieux, S., Baeke, A., Kendall, D., De Neef, J., Soenen, A., Puech, P. Y., Ward, J., Jamoye, J. F., Diez, D., Vicario-Arroyo, A., & Jankowski, M. (2015). NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 1--design, manufacturing and testing of the infrared channels. Applied optics, 54(28), 8494-520. https://doi.org/10.1364/AO.54.008494
Neefs, Eddy, et al. "NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 1--design, manufacturing and testing of the infrared channels." Applied optics vol. 54,28 (2015): 8494-520. doi: https://doi.org/10.1364/AO.54.008494
Neefs E, Vandaele AC, Drummond R, Thomas IR, Berkenbosch S, Clairquin R, Delanoye S, Ristic B, Maes J, Bonnewijn S, Pieck G, Equeter E, Depiesse C, Daerden F, Van Ransbeeck E, Nevejans D, Rodriguez-Gómez J, López-Moreno JJ, Sanz R, Morales R, Candini GP, Pastor-Morales MC, Aparicio del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, Thibert T, Patel MR, Bellucci G, De Vos L, Lesschaeve S, Van Vooren N, Moelans W, Aballea L, Glorieux S, Baeke A, Kendall D, De Neef J, Soenen A, Puech PY, Ward J, Jamoye JF, Diez D, Vicario-Arroyo A, Jankowski M. NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 1--design, manufacturing and testing of the infrared channels. Appl Opt. 2015 Oct 01;54(28):8494-520. doi: 10.1364/AO.54.008494. PMID: 26479628.
Copy Download .nbib Format: NLM
Pulmonary hypertension in adult congenital heart disease.

Current treatment options in cardiovascular medicine

Rodriguez-Lopez J.
PMID: 24942698
Curr Treat Options Cardiovasc Med. 2014 Aug;16(8):328. doi: 10.1007/s11936-014-0328-z.

OPINION STATEMENT: There is a growing patient population with adult congenital heart disease that needs specialized medical attention and careful long-term evaluation. Pulmonary arterial hypertension (PAH) associated with congenital heart disease (PAH-CHD) is a common late complication, and is...

Cite
Rodriguez-Lopez J. Pulmonary hypertension in adult congenital heart disease. Curr Treat Options Cardiovasc Med. 2014;16(8):328doi: 10.1007/s11936-014-0328-z.
Rodriguez-Lopez, J. (2014). Pulmonary hypertension in adult congenital heart disease. Current treatment options in cardiovascular medicine, 16(8), 328. https://doi.org/10.1007/s11936-014-0328-z
Rodriguez-Lopez, Josanna. "Pulmonary hypertension in adult congenital heart disease." Current treatment options in cardiovascular medicine vol. 16,8 (2014): 328. doi: https://doi.org/10.1007/s11936-014-0328-z
Rodriguez-Lopez J. Pulmonary hypertension in adult congenital heart disease. Curr Treat Options Cardiovasc Med. 2014 Aug;16(8):328. doi: 10.1007/s11936-014-0328-z. PMID: 24942698.
Copy Download .nbib Format: NLM
Endovascular grafts for thoracic aortic pathologies.

Multimedia manual of cardiothoracic surgery : MMCTS

Shennib H, Turina M, Ramaiah VG, Rodriguez-Lopez J, Wheatley G, Kpodonu J, Diethrich E.
PMID: 24415547
Multimed Man Cardiothorac Surg. 2008 Jan 01;2008(523):mmcts.2007.003095. doi: 10.1510/mmcts.2007.003095.

Endovascular aortic repair (EVAR) is rapidly being adopted to capture a substantial proportion of surgical candidates with aneurysmal disease of the descending thoracic aorta. This new technique requires both special equipment (hybrid operating room, full range of catheterization tools)...

Cite
Shennib H, Turina M, Ramaiah VG, et al. Endovascular grafts for thoracic aortic pathologies. Multimed Man Cardiothorac Surg. 2008;2008(523):mmcts.2007.003095doi: 10.1510/mmcts.2007.003095.
Shennib, H., Turina, M., Ramaiah, V. G., Rodriguez-Lopez, J., Wheatley, G., Kpodonu, J., & Diethrich, E. (2008). Endovascular grafts for thoracic aortic pathologies. Multimedia manual of cardiothoracic surgery : MMCTS, 2008(523), mmcts.2007.003095. https://doi.org/10.1510/mmcts.2007.003095
Shennib, Hani, et al. "Endovascular grafts for thoracic aortic pathologies." Multimedia manual of cardiothoracic surgery : MMCTS vol. 2008,523 (2008): mmcts.2007.003095. doi: https://doi.org/10.1510/mmcts.2007.003095
Shennib H, Turina M, Ramaiah VG, Rodriguez-Lopez J, Wheatley G, Kpodonu J, Diethrich E. Endovascular grafts for thoracic aortic pathologies. Multimed Man Cardiothorac Surg. 2008 Jan 01;2008(523):mmcts.2007.003095. doi: 10.1510/mmcts.2007.003095. PMID: 24415547.
Copy Download .nbib Format: NLM
[No title available]

Nefrologia

Calle Garcia L, Martin Varas C, Urzola Rodriguez G, Marcos Hidalgo M, Rodriguez Gomez A, Molina Ordas A, Fidalgo Gonzalez V, Sanchez Garrote P, Garcia Gutierrez P, Garcia De Burgos M, Fernandez-Reyes Luis MJ.
PMID: 34602693
Nefrologia (Engl Ed). 2021 Sep 29; doi: 10.1016/j.nefro.2021.09.005. Epub 2021 Sep 29.

No abstract available.

Cite
Calle Garcia L, Martin Varas C, Urzola Rodriguez G, et al. Hematuria Macroscopica En Pacientes Con Nefropatía Iga Tras Vacuna Para Sars-Cov-2. . Nefrologia (Engl Ed). 2021;doi: 10.1016/j.nefro.2021.09.005.
Calle Garcia, L., Martin Varas, C., Urzola Rodriguez, G., Marcos Hidalgo, M., Rodriguez Gomez, A., Molina Ordas, A., Fidalgo Gonzalez, V., Sanchez Garrote, P., Garcia Gutierrez, P., Garcia De Burgos, M., & Fernandez-Reyes Luis, M. J. (2021). Hematuria Macroscopica En Pacientes Con Nefropatía Iga Tras Vacuna Para Sars-Cov-2. . Nefrologia, . https://doi.org/10.1016/j.nefro.2021.09.005
Calle Garcia, L, et al. "Hematuria Macroscopica En Pacientes Con Nefropatía Iga Tras Vacuna Para Sars-Cov-2." . Nefrologia vol. (2021). doi: https://doi.org/10.1016/j.nefro.2021.09.005
Calle Garcia L, Martin Varas C, Urzola Rodriguez G, Marcos Hidalgo M, Rodriguez Gomez A, Molina Ordas A, Fidalgo Gonzalez V, Sanchez Garrote P, Garcia Gutierrez P, Garcia De Burgos M, Fernandez-Reyes Luis MJ. Hematuria Macroscopica En Pacientes Con Nefropatía Iga Tras Vacuna Para Sars-Cov-2. . Nefrologia (Engl Ed). 2021 Sep 29; doi: 10.1016/j.nefro.2021.09.005. Epub 2021 Sep 29. Spanish. PMID: 34602693; PMCID: PMC8479421.
Copy Download .nbib Format: NLM
COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey.

Revista panamericana de salud publica = Pan American journal of public health

Ramonfaur D, Hinojosa-González DE, Rodriguez-Gomez GP, Iruegas-Nuñez DA, Flores-Villalba E.
PMID: 34703461
Rev Panam Salud Publica. 2021 Oct 18;45:e133. doi: 10.26633/RPSP.2021.133. eCollection 2021.

OBJECTIVE: To identify factors associated with COVID-19 vaccine hesitancy and acceptance among the Mexican population.METHODS: In a web-based nationwide survey in early December 2020, respondents were inquired about their sociodemographic characteristics and their willingness to accept a hypothetical COVID-19...

Cite
Ramonfaur D, Hinojosa-González DE, Rodriguez-Gomez GP, et al. COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey. Rev Panam Salud Publica. 2021;45:e133doi: 10.26633/RPSP.2021.133.
Ramonfaur, D., Hinojosa-González, D. E., Rodriguez-Gomez, G. P., Iruegas-Nuñez, D. A., & Flores-Villalba, E. (2021). COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey. Revista panamericana de salud publica = Pan American journal of public health, 45e133. https://doi.org/10.26633/RPSP.2021.133
Ramonfaur, Diego, et al. "COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey." Revista panamericana de salud publica = Pan American journal of public health vol. 45 (2021): e133. doi: https://doi.org/10.26633/RPSP.2021.133
Ramonfaur D, Hinojosa-González DE, Rodriguez-Gomez GP, Iruegas-Nuñez DA, Flores-Villalba E. COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey. Rev Panam Salud Publica. 2021 Oct 18;45:e133. doi: 10.26633/RPSP.2021.133. eCollection 2021. PMID: 34703461; PMCID: PMC8529997.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 28 entries